Solid Biosciences Inc (SLDB)
8.89
+0.10
(+1.14%)
USD |
NASDAQ |
Apr 30, 16:00
8.89
0.00 (0.00%)
After-Hours: 16:23
Solid Biosciences Free Cash Flow: -95.70M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -95.70M |
September 30, 2023 | -110.12M |
June 30, 2023 | -113.11M |
March 31, 2023 | -102.12M |
December 31, 2022 | -100.99M |
September 30, 2022 | -87.19M |
June 30, 2022 | -84.58M |
March 31, 2022 | -85.02M |
December 31, 2021 | -79.04M |
September 30, 2021 | -56.26M |
June 30, 2021 | -53.25M |
March 31, 2021 | -48.94M |
December 31, 2020 | -57.50M |
Date | Value |
---|---|
September 30, 2020 | -80.64M |
June 30, 2020 | -84.88M |
March 31, 2020 | -99.18M |
December 31, 2019 | -97.10M |
September 30, 2019 | -98.05M |
June 30, 2019 | -95.57M |
March 31, 2019 | -87.68M |
December 31, 2018 | -77.97M |
September 30, 2018 | -69.44M |
June 30, 2018 | -63.13M |
March 31, 2018 | -53.23M |
December 31, 2017 | -45.50M |
Free Cash Flow Range, Past 5 Years
-113.11M
Minimum
Jun 2023
-48.94M
Maximum
Mar 2021
-85.75M
Average
-87.19M
Median
Sep 2022
Free Cash Flow Benchmarks
Sarepta Therapeutics Inc | -588.34M |
PTC Therapeutics Inc | -199.47M |
Capricor Therapeutics Inc | -27.64M |
Perspective Therapeutics Inc | -37.98M |
Electromed Inc | 3.653M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -20.82M |
Cash from Investing (Quarterly) | 45.30M |
Cash from Financing (Quarterly) | 0.505M |
Free Cash Flow Per Share (Quarterly) | -1.034 |
Free Cash Flow Yield | -54.14% |